Category Archives: Articles

The Messy Truth about Hybrid Work

In Newsweek

From my feature story in the Sept. 29, 2023, issue of Newsweek

Headlines have been screaming lately that America’s honeymoon with remote work is over. These claims miss the mark. The evidence suggests that the full-time office workweek is unlikely to return to most organizations any time in the foreseeable future. What may have started as a pandemic-era dalliance has become, in only a few short years, deeply embedded in America’s workstyle. But there’s a catch….Read more

Science Says Everything You Know about Food, Diet and Drugs is Wrong

In Newsweek

From my article in the September 8, 2023, issue of Newsweek

….Diets that emphasize intermittent fasting, nurturing good gut bacteria and cutting out carbs have surged in popularity, but their basis in science is sketchy. The arrival of a new generation of astonishingly effective weight-loss drugs offers the tantalizing prospect of blunting America’s obesity problem. But it’s not clear if a lifetime drug regime will be safe or affordable for the 42 percent of Americans who are obese….Read more

Three planet heroes

In Newsweek

From my articles in the Aug. 19, 2023, issue of Newsweek

An artist whose works evoke iconic works of the 1940s, 50s and 60s hit home the grim future awaiting our landscapes if we don’t stop climate change. A refugee of the Rwandan genocide helps the electric grid enlist AI to keep the lights in extreme weather. A college grad who couldn’t find a job in environmentalism becomes a powerful voice for diversity in the eco-industry. These three innovators show how the inspiration to save the climate can come from unexpected sources.

Ultra-Sustainable Building Technologies Are Hitting the Mainstream

In Newsweek

From my article in Newsweek, posted August 14, 2023

Trondheim, Norway, a city of 180,000 just 200 miles from the Arctic Circle on the coast of the frigid Norwegian Sea, hardly seems an ideal location for harvesting energy from the sun and surrounding environment. But a new 200,000-square-foot office building there is producing nearly half a million kilowatt-hours of renewable energy per year—twice as much as the building uses. The extra energy is powering other nearby buildings and charging electric cars, buses and boats throughout the city.

….A confluence of new technologies and improving economics, as well as climate-change-inspired government regulation, are leading to the next wave in big construction: ultra-sustainable buildings….Read more

How AI Will Make Our Lives Better (And Worse)

In Newsweek

From my article in the June 9, 2023, issue of Newsweek

The explosion of progress in artificial intelligence in recent months has surprised even the scientists and engineers who specialize in applying AI to real-world tasks. “A few years ago I never would have imagined we’d advance this far this soon,” says Zhe Jiang, a University of Florida researcher who studies industrial applications of AI.

The recent excitement—and concerns—over this technology were ignited when several major companies released stunningly capable new programs in swift succession, including OpenAI’s ChatGPT, Microsoft’s Bing and Google’s Bard. These “large language models” are programmed to pore over trillions of words of text from the internet to learn how to produce very human-like text and images on their own in response to plain English questions and requests….Read more

How the Opioid Backlash Went Wrong

In Newsweek

From my cover story in the May 12, 2023, issue of Newsweek

Danny Barcelona lives in constant fear that doctors will stop the medications he considers lifesaving. The 66-year-old has suffered for more than two decades with a debilitating nervous-system disorder and severe back and shoulder pain, forcing him to close his once-thriving dental-lab business in Asheville, North Carolina, and sometimes leaving him bedridden for 18 hours a day. That he can function at all, he says, is due to his ongoing prescription for oxycodone, an opioid….Read more

“It’s a Cyber Pandemic.”

In Newsweek

From my cover story in the Jan. 27, 2023, issue of Newsweek

More than 70 million Americans are hit by cybercrimes every year, often leaving people defrauded, spied on or publicly humiliated by having private photos and other information published online. More than two-thirds of small businesses have been victimized by hackers at least once. Some experts believe that just about every large organization and government agency has been breached. Last year, 22 billion personal and business records were exposed in hacks on U.S. companies—and that doesn’t include breaches that were unidentified or unreported, which may well represent the majority of hacks. As bad as it’s been, it’s getting worse….Read more

Will Gov. Gavin Newsom’s Electric Car Mandate Save the World or Stall on the Freeway?

In Newsweek

From my cover story in the Dec. 16, 2022, issue of Newsweek

No state is more car-crazy than California—and they’ve paid a big price for it, not just in $6-per-gallon gas. The heat waves, droughts and calamitous wildfires that have ravaged the state in recent years are by-products of climate change, to which greenhouse-gas emissions from California tailpipes (and elsewhere) have contributed. To Governor Gavin Newsom and other state political leaders, the fix is clear: Regulate the tailpipe out of existence….Read more

Sweet Revenge: What Trump Would Do in a Second Term

In Newsweek

Mastodon

From my cover story in the Nov. 4, 2022, issue of Newsweek

The specifics of Trump 47’s policies—to the extent that Trump bothers with policies—are a matter of speculation. But some broader actions seem certain, according to current and former Trump insiders interviewed by Newsweek: avoiding his first-term approach of appointing people who might protect him from his worst instincts and instead packing the administration with loyalists; trying to get a firmer grip on the military with an eye to consolidating power; drastically shrinking the civil service and throwing a steady diet of red-meat culture-war goodies at his base….Read more

Can Kickstarter’s new CEO help the company get its mojo back?

In Fast Company

From my article in Fast Company, posted October 3, 2022

One of the tech darlings to come out of the Great Recession of the late 2000s, Kickstarter popularized crowdfunding. Since its founding in 2009, its platform has helped to raise $5 billion, launching more than 220,000 projects, including businesses like Oculus, Allbirds, and Peloton. The number of funded projects on the site is reaching new heights, and this year 54% of all projects have hit their funding goals, steadily up from less than 43% in 2018. But the past couple of years haven’t been entirely smooth sailing for the company. And now, a new CEO is hoping to get it back on course….Read more

How COVID Opened a Pandora’s Box of Infectious Diseases

In Newsweek

From my cover story in the September 9, 2022, issue of Newsweek

As the world grapples with the reality of living with COVID-19, a rogue’s gallery of deadly pathogens seems to have stepped up the attack. Monkeypox, a close relation of smallpox, is officially a public health emergency worldwide. The current outbreak—the first large one ever outside of Africa—has spread globally to more than 45,000 people, including more than 16,000 confirmed cases in the U.S. And polio, a disease routinely referred to as “eradicated,” is circulating in and around New York City and London, bringing with it the irreversible paralysis that strikes about one of 200 people infected with the disease….Read more

How will medicine deal with AI’s mistakes?

In The Yuan

From my article in The Yuan, posted August 1, 2022

Medical errors cost the lives of some 250,000 people a year in the U.S. alone, calculates the BMJ, making them the third leading cause of death, with a price tag of some $20 billion a year. Research suggests AI can help cut this staggeringly high error rate. For example, AI systems have been shown in different studies to exceed physicians’ accuracy in diagnosing cancer in both pathology slides and imaging, and in detecting brain hemorrhages that lead to stroke, reducing both false positives and false negatives.

But even if AI systems get it wrong at a lower rate than physicians, they may still be seen as causing more problems than they solve. That’s because there is a well-established infrastructure designed to catch, analyze, prevent and correct conventional medical errors. But there is as of yet little such infrastructure for AI medical errors….Read more

Will Trump Do Time?

In Newsweek

From my cover story in the July 29, 2022, issue of Newsweek

“It’s no longer premature to say that Trump could end up in prison,” says Michael Conway, a longtime trial lawyer who started his career as counsel for the House Judiciary Committee during the impeachment inquiry into Richard Nixon in 1974 , and who now teaches ethics and the law at Northwestern University. “It’s a winnable case.” Here’s a look at what charges Trump may well be facing—and, if they are in fact brought against him, how the results are likely to play out in the courtroom and conceivably the prison system….Read more

Abortion, Science and Post-Roe America

In Newsweek

From my cover story in the June 24, 2022, issue of Newsweek

In the half-century since Roe v. Wade, the science of fetal development and early birth has advanced considerably. Neonatal physicians and researchers have modified their thinking on when a fetus is and isn’t viable outside the womb, on how it makes the transition from a bundle of cells to a thinking, feeling being, on the relationship between a fetus and the health of the mother and on the many factors that determine whether a particular premature birth will be successful….Read more

Big Tech’s Reckoning

In Newsweek

From my cover story in the May 13, 2022, issue of Newsweek

In February, the company formerly known as Facebook lost $232 billion in value in the stock market. Meta Platforms, as the company is now formally known, can only wish that a brutal stock beating is its only problem. The company is also facing a daunting level of ire, which is splashing over onto the rest of Big Tech—that is, Google, Amazon, Apple and Microsoft. These tech giants are facing scrutiny from regulators and legislators both in the U.S. and Europe. And they are all objects of an intensifying resentment on the part of the public….Read more

Tiny Reactors Could Spark a Nuclear Revolution to Fight Climate Change

In Newsweek

From my article in the January 21, 2022, issue of Newsweek (posted online 1/12/22)

A new generation of nuclear reactors is emerging as a potential solution to climate change. The new reactors are designed to be simpler, safer, cheaper and much, much smaller. One tiny reactor the size of a school bus could supply power to a nearby town or factory. Or many of them could be strung together to equal the output of a giant nuclear plant. Not only are they expected to be safer and to produce electricity more cheaply than conventional nuclear plants, they also do so without releasing so much as a puff of greenhouse gas….Read more

If Trump cries foul in 2024, millions of armed Americans might respond

In Newsweek

From my article in the January 14, 2022, issue of Newsweek (posted online 12/20/21)

Mike “Wompus” Nieznany is a 73-year-old Vietnam veteran who walks with a cane from the combat wounds he received during his service. That disability doesn’t keep Nieznany from making a living selling custom motorcycle luggage racks from his home in Gainesville, Georgia. Neither will it slow him down when it’s time to visit Washington, D.C.—heavily armed and ready to do his part in overthrowing the U.S. government.

Nieznany represents something beyond militia: a much larger and more diffuse movement of more-or-less ordinary people, stoked by misinformation, knitted together by social media and well-armed….Read more

Is Ivermectin “Bogus,” or a “Miracle Drug”?

In Newsweek

ivermectin clinical trial

From my article online in Newsweek, posted October 5, 2021

The reluctance of scientists, doctors and regulators to endorse ivermectin as a COVID-19 treatment has inflamed the political right in the U.S. Conservative pundits have called it a “miracle drug,” and even some prominent Republican members of Congress are fuming. The reaction on the political left has been nearly as hyperbolic, with headlines calling it a “bogus COVID treatment” and “a darling of conspiracy-mongers”….Read more

Are we ready for virtual war?

In Newsweek

FE Cover Military AI BANNER

The US is the only nation with ethical standards for AI Weapons. Should we be afraid?

From my cover story in the Sept. 24, 2021, issue of Newsweek

At a time when the U.S. has pulled its troops from Afghanistan and is reluctant to commit them to other conflicts around the world, the ability to attack from a distance with unmanned weapons is becoming a key element of U.S. military strategy. Artificial intelligence, by endowing machines with the ability to make battlefield decisions on their own, makes this strategy viable. Plans are being laid to include AI in a whole arsenal of weaponry, ranging from fighter jets to submarines to missiles, which will be able to strike at terrorists and enemy forces entirely under their own control–humans, optional….Read more

A Doomsday COVID Variant Worse Than Delta and Lambda May Be Coming, Scientists Say

In Newsweek

From my cover story in the August 13, 2021, issue of Newsweek

Delta, like most of the other variants, blindsided us, worsening and extending the pandemic. And the outbreak is going to get much worse, warns Michael Osterholm, an epidemiologist who leads the Center for Infectious Disease Research and Policy at the University of Minnesota. “The number of intensive-care beds needed could be higher than any time we’ve seen,” he says. When the damage from Delta starts to subside, what other variants will be lurking just behind it to pull us back down again? The World Health Organization is already keeping an eye on several….Read more

The quest for rest

In Fortune

Sleep could be the key to fighting Alzheimer’s—and a huge business opportunity

From my article in Fortune, posted July 31, 2021

Last year Miranda Lim found that taking care of three young children homebound by the pandemic meant she often had to work late into the evening to stay on top of her job. So she set up a daily alarm—not for waking up, but for heading off to bed at a reasonable hour.

It’s understandable why Lim would be a bit of an alarmist, so to speak, when threatened with a lack of a consistent night’s sleep. A neurologist at the Oregon Health & Science University and a sleep disorders physician at the VA Portland Health Care System, Lim is at the forefront of a global cadre of medical researchers who have in recent years been pinning down the ways in which even moderate sleep deficiencies in middle age strongly link to Alzheimer’s disease and dementia later in life…. Read more [may be paywalled]

Why Ripple’s SEC lawsuit could have a lasting impact on crypto

In Fortune

From my article on Fortune.com, posted July 29, 2021

Trade Crypto for Less Coin | Interactive Brokers LLC

Nine years ago a startup that would eventually be called Ripple Labs came onto the fintech scene with a promising plan to provide financial institutions with fast, low-cost clearance of trans-border money transfers. To make it happen, the company set up a network on which transactions sped across the globe in the form of a cryptocurrency called XRP, which was specially created for the task.

But thanks to its eventual popularity outside of that application, XRP has turned out to be a sort of time bomb with a very long fuse for Ripple….Read more

Chris Evans Wants to Help Gen Z Reshape US Politics

In Newsweek

From my cover story in the June 18, 2021, issue of Newsweek

Members of Congress get a lot of calls from people wanting things, most of which receive polite regrets from staffers. But lately one particular call is consistently getting past the gatekeepers: the one from Chris Evans.

Yes, that Chris Evans.

For a year and a half, the 39-year-old megastar (he turns 40 on June 13), best known for playing Captain America in the Marvel movies, has been quietly working the halls of the Capitol, occasionally in person, in an effort to persuade senators and representatives to put aside their hyper-partisan hyperbole and explain, in under two minutes, their views on politics and policy to a new generation of young potential voters….Read more

Stop Worrying About Free Beer and Doughnuts. We’re in the Middle of a Pandemic.

In The Atlantic

A needle formed by hundred-dollar bills

For too long, we’ve believed the myth that incentives backfire. But there’s nothing wrong with bribing people to get vaccinated.

From my article in The Atlantic, posted May 19, 2021

A stream of grumbling recently turned up in my Twitter feed over incentives that are being offered to encourage Americans to get a COVID-19 vaccine, including money, beer, doughnuts and even weed. The idea that society is better off when people act on “intrinsic” motivation—that is, because they’re inclined to do the right thing—and not on “extrinsic” motivation, such as receiving a cash payment, is widespread. But is there really something inherently wrong with bribing people to do the right thing? And on a practical level, does it work?….Read more

Tagged

Time for a third party?

In Newsweek

Everything Liz Cheney Has Said About Trump

From my article in Newsweek, posted May 12, 2021

Republicans have stripped Liz Cheney of her leadership role, following her outspoken repudiation of former President Donald Trump’s baseless claims of election fraud. Which raises a question: Might Cheney, along with other prominent Republicans on the outs with the party because they have withheld fealty to the former president, mount their next election bids as independents—or even form a third party? The odds may be better than you think….Read more

Can Biden Fix Healthcare?

In Newsweek

A Healthcare and Public Health Shakeup Is on Democrats’ Agenda

From my cover story in the March 12, 2021, edition of Newsweek

America has a long, sorry record of neglect, poor organization, underfunding, and misplaced priorities when it comes to public health. Add to those woes the sky-high cost of health care, uneven access and relatively poor outcomes, and it’s clear the American public has been living for decades with a health system that is failing. Can Joe Biden get American health back on track?….Read more

Are we losing the race between the vaccines and the mutations?

In Newsweek

From my article in Newsweek, posted Jan. 28, 2021

The virus is changing. It has already mutated into versions that spread more quickly, may kill more efficiently and threaten to undermine the effectiveness of vaccines. The nightmare scenario: the virus mutates into a variant that renders current vaccines weakened or obsolete before the rollout reaches the 150 million or so people needed to achieve herd immunity, which would halt the virus in its tracks….Read more

Facebook’s Plan to Dominate Virtual Reality

In Newsweek

Under Facebook’s leadership, VR could change our lives. Will it also turn us into ‘data cattle’?

From my article in Newsweek, posted Dec. 23, 2020

If Facebook succeeds in its quest to bring VR to social-media masses, it could bring a level of realism and ease-of-use to remote interactions that makes Zoom video look like stone tablets by comparison. It would also position itself to determine not just how we swap posts online, but much of what we experience in an increasingly simulated world—in work, play, education, family, health, commerce and even love….Read more

FedEx Gears Up for All-Out War With Amazon

In Marker

The pandemic turbo-charged e-commerce — now the two giants are battling over the future of shipping

From my article in Marker, posted Dec. 1, 2020

Seven years ago, frustrated with FedEx and UPS delivery delays during the 2013 holiday rush, Amazon began building out its own delivery network for the products it sells and ships. Now Amazon is greasing its delivery network to deliver a much bigger blow: Going into business as a third-party shipper looking to steal business from FedEx and other shippers. But long known as the highest-tech shipper, FedEx is preparing for an all-out battle for shipping dominance, hoping it can get ahead of the one company that has managed to upend virtually every industry it’s touched….Read more

As QAnon Draws New Believers, Scientists Take Aim at a Misinformation Pandemic

In Newsweek

A cadre of scientists are at the forefront of efforts to map QAnon and understand how it works.

From my cover story in the Oct. 23, 2020, issue of Newsweek

The explosion of disinformation that has upended American life and now threatens its democratic institutions has given rise to a new branch of science called “infodemiology.” Inspired by epidemiology, the study of how diseases spread through a population, infodemiology seeks to understand how misinformation and conspiracy theories spread like a disease through a free-wheeling democracy like America’s, with the ultimate goal of understanding how to stem its spread….Read more